Terms: = Skin cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
14 results:
1. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract] [Full Text] [Related]
2. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
[TBL] [Abstract] [Full Text] [Related]
3. TET2 and dnmt3a mutations and exceptional response to 4'-thio-2'-deoxycytidine in human solid tumor models.
Yang SX; Hollingshead M; Rubinstein L; Nguyen D; Larenjeira ABA; Kinders RJ; Difilippantonio M; Doroshow JH
J Hematol Oncol; 2021 May; 14(1):83. PubMed ID: 34039392
[TBL] [Abstract] [Full Text] [Related]
4. Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
Patrinely JR; Johnson R; Lawless AR; Bhave P; Sawyers A; Dimitrova M; Yeoh HL; Palmeri M; Ye F; Fan R; Davis EJ; Rapisuwon S; Long GV; Haydon A; Osman I; Mehnert JM; Carlino MS; Sullivan RJ; Menzies AM; Johnson DB
JAMA Oncol; 2021 May; 7(5):744-748. PubMed ID: 33764387
[TBL] [Abstract] [Full Text] [Related]
5. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
6. SUV39H1/dnmt3a-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development.
Kim G; Kim JY; Lim SC; Lee KY; Kim O; Choi HS
FASEB J; 2018 Oct; 32(10):5647-5660. PubMed ID: 29750576
[TBL] [Abstract] [Full Text] [Related]
7. DNA Methyltransferase Gene Polymorphisms for Prediction of Radiation-Induced skin Fibrosis after treatment of Breast cancer: A Multifactorial Genetic Approach.
Terrazzino S; Deantonio L; Cargnin S; Donis L; Pisani C; Masini L; Gambaro G; Canonico PL; Genazzani AA; Krengli M
Cancer Res Treat; 2017 Apr; 49(2):464-472. PubMed ID: 27554481
[TBL] [Abstract] [Full Text] [Related]
8. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract] [Full Text] [Related]
9. Malignancies of the anal canal: a multi-center retrospective analysis in South China population.
Sun P; Li YH; Wang W; Chen CQ; Wang LY
J BUON; 2014; 19(1):103-8. PubMed ID: 24659650
[TBL] [Abstract] [Full Text] [Related]
10. Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators.
Vaid M; Prasad R; Singh T; Jones V; Katiyar SK
Toxicol Appl Pharmacol; 2012 Aug; 263(1):122-30. PubMed ID: 22749965
[TBL] [Abstract] [Full Text] [Related]
11. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract] [Full Text] [Related]
12. Clinical assessment of three-dimensional ultrasound prostate localization for external beam radiotherapy.
Orton NP; Jaradat HA; Tomé WA
Med Phys; 2006 Dec; 33(12):4710-7. PubMed ID: 17278823
[TBL] [Abstract] [Full Text] [Related]
13. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity.
Yakushiji T; Uzawa K; Shibahara T; Noma H; Tanzawa H
Int J Oncol; 2003 Jun; 22(6):1201-7. PubMed ID: 12738984
[TBL] [Abstract] [Full Text] [Related]
14. Phase I clinical trial of an MAF-containing lymphoblastoid cell line supernatant.
Reynolds RD; McEntire JE; Rodes ND; Dunn PA; Walter J; Doyle MK; Anson NO; Garcia A; Oxenhandler RW; Khojasteh A
J Biol Response Mod; 1986 Apr; 5(2):129-39. PubMed ID: 3525761
[TBL] [Abstract] [Full Text] [Related]